Dr. Deborah Doroshow, MD, PhD
Claim this profileMount Sinai Hospital
Area of expertise
Cancer
Deborah Doroshow, MD, PhD has run 7 trials for Cancer. Some of their research focus areas include:
Solid Tumors
Deborah Doroshow, MD, PhD has run 7 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
Mount Sinai Hospital
Icahn School Of Medicine At Mount Sinai
Clinical Trials Deborah Doroshow, MD, PhD is currently running
SGR-3515
for Advanced Cancer
The purpose of this study is to learn about the effects of a new study drug, called SGR-3515 that may be a treatment for advanced solid tumors.
Recruiting
1 award
Phase 1
2 criteria
Leflunomide
for Solid Tumors
Leflunomide in patients with PTEN-Altered advanced solid tumors or HER2 negative breast cancer. Phase 1A objectives are to determine the safety, tolerability, and the MTD of leflunomide in patients with PTEN-Altered advanced solid malignancies and HER2 negative breast cancer. Phase 1B objective is to assess preliminary evidence of clinical activity of leflunomide in these patient populations.
Recruiting
1 award
Phase 1
More about Deborah Doroshow, MD, PhD
Clinical Trial Related
6 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Deborah Doroshow, MD, PhD has experience with
- Paclitaxel
- Pembrolizumab
- Atezolizumab
- Ipatasertib
- Binimetinib
- Palbociclib
Breakdown of trials Deborah Doroshow, MD, PhD has run
Cancer
Solid Tumors
Lung Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Deborah Doroshow, MD, PhD specialize in?
Deborah Doroshow, MD, PhD focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Deborah Doroshow, MD, PhD currently recruiting for clinical trials?
Yes, Deborah Doroshow, MD, PhD is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Deborah Doroshow, MD, PhD has studied deeply?
Yes, Deborah Doroshow, MD, PhD has studied treatments such as Paclitaxel, Pembrolizumab, Atezolizumab.
What is the best way to schedule an appointment with Deborah Doroshow, MD, PhD?
Apply for one of the trials that Deborah Doroshow, MD, PhD is conducting.
What is the office address of Deborah Doroshow, MD, PhD?
The office of Deborah Doroshow, MD, PhD is located at: Mount Sinai Hospital, New York, New York 10029 United States. This is the address for their practice at the Mount Sinai Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.